<DOC>
	<DOCNO>NCT00770718</DOCNO>
	<brief_summary>The purpose dose-ranging pilot study compare Recombinant Activated Factor VII , Prothrombin Complex Concentrate Fresh Frozen Plasma ( start low dos escalation necessary ) reversal warfarin set acute intracranial hemorrhage .</brief_summary>
	<brief_title>Factor VII , Prothrombin Complex Concentrate , Fresh Frozen Plasma Warfarin-Related Intracranial Hemorrhage</brief_title>
	<detailed_description>Both recombinant activate Factor VIIa ( rFVIIa ) well Prothrombin Complex Concentrate ( PCC ) label treatment bleeding episodes patient hemophilia . Many hospital also use follow unlabeled indication : bleeding rescue surgical patient , severe multiple trauma ongoing bleeding , intracranial bleeding &lt; 4 hour since symptom onset , traumatic head injury evidence expand bleed , retroperitoneal bleed , life-threatening bleeding due idiopathic coagulopathy . To knowledge , two product never clinically compare head head reversal warfarin set intracranial hemorrhage . The rFVIIa ( Novoseven ) guideline base national data utilize dose range 40-90 mcg/kg ideal body weight ( 2.8-6.3 mg 70 kg . patient ) additional dose need . The dose cite literature management intracerebral bleeds range 10 120 mcg/kg ( 0.7 - 8.4 mg 70 kg . patient , ) high dos associate increase risk thromboembolic event . The recommended dosing PCC 30-50 i.u . per kilogram ideal body weight additional dosing need . PCC ( Profilnine®SD ) mixture follow vitamin K-dependent clotting factor : II ( prothrombin ) , VII ( proconvertin ) , IX ( plasma thromboplastin component ; PTC ; Christmas factor ) , X ( Stuart-Prower factor ) . These factor require conversion prothrombin thrombin thus adequate hemostasis , synthesize liver . Currently hospitals around country , fresh frozen plasma ( FFP ) mainstay reversal warfarin-related coagulopathy intracranial hemorrhage discretion treat attend physician . We propose study current reversal practice intracranial hemorrhage population University Utah part quality improvement project patient safety cost . We perform safety feasibility study compare dosage regimen rFVIIa , FIXa fresh frozen plasma ( FFP ) infusion normalization coagulopathy context warfarin-related intracerebral hemorrhage . Our primary outcome time INR normalization define INR≤ 1.3 two consecutive reading separate 2 hour .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Intracranial Hemorrhages</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<criteria>Nontraumatic intracranial hemorrhage ( subdural intraparenchymal ) Known warfarin ingestion INR ≥2.0 GCS &lt; 13 Pregnancy History venous thrombosis pulmonary embolus Acute myocardial infarction Acute stroke</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>intracranial hemorrhage</keyword>
	<keyword>warfarin</keyword>
	<keyword>anticoagulant</keyword>
	<keyword>Factor VII</keyword>
	<keyword>Prothrombin</keyword>
</DOC>